ABBV dividend yield: 3.67%. QYLD dividend yield: 11.43%. AbbVie is a pharmaceutical giant best known for Humira and newer blockbusters Skyrizi and Rinvoq. A Dividend Aristocrat with 52+ years of consecutive dividend increases. Strong free cash flow generation supports its above-average yield. The company's diversified pipeline reduces dependence on any single drug. QYLD sells covered calls on the full Nasdaq 100 index, generating very high monthly income (10%+ yield). The strategy caps upside participation in exchange for income. Best suited for investors who prioritize maximum current income over capital appreciation. NAV erosion over time is a known trade-off.
AbbVie is a pharmaceutical giant best known for Humira and newer blockbusters Skyrizi and Rinvoq. A Dividend Aristocrat with 52+ years of consecutive dividend increases. Strong free cash flow generation supports its above-average yield. The company's diversified pipeline reduces dependence on any single drug.
QYLD sells covered calls on the full Nasdaq 100 index, generating very high monthly income (10%+ yield). The strategy caps upside participation in exchange for income. Best suited for investors who prioritize maximum current income over capital appreciation. NAV erosion over time is a known trade-off.
Is ABBV or QYLD better for dividend income in 2026?
ABBV currently offers a 3.67% yield (6.20/share/year) while QYLD offers 11.43% (1.92/share/year). QYLD provides higher current income. However, ABBV has grown its dividend faster (8.9% 5Y CAGR), which may lead to better long-term income through compounding.
How much would $10,000 in ABBV vs QYLD earn per year?
With $10,000 invested today: ABBV pays approximately $367/year. QYLD pays approximately $1143/year. With DRIP reinvestment over 10 years, these grow to $1,154/year (ABBV) and $3,554/year (QYLD).
Does ABBV or QYLD pay monthly dividends?
ABBV pays quarterly dividends. QYLD pays monthly dividends. QYLD pays monthly, which is preferred by investors who need regular cash flow.
📬
Get this ABBV vs QYLD comparison by email
Save your analysis + get weekly dividend insights. Free forever.